Trial Profile

A Pilot Study on Safety, Feasibility and Insulin-promotion by Intra-inguinal Lymph Node Injections of Glutamic Acid Decarboxylase (GAD) in Patients With LADA Type of Diabetes

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 22 Aug 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Autoimmune-diabetes-vaccine-(Diamyd)-Diamyd-Medical (Primary) ; Vitamin D
Indications Latent autoimmune diabetes in adults
Focus Adverse reactions; Pharmacodynamics
Acronyms GADinLADA

Most Recent Events

16 Aug 2023 According to a Diamyd Medical media release, results are now published in the peer-reviewed scientific journal Diabetes Obesity and Metabolism.
16 Aug 2023 Results published in a Diamyd Medical media release
14 Aug 2023 Results evaluating the safety of the treatment, published in the Diabetes, Obesity and Metabolism.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com